Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Kwality Pharmaceuticals Limited (NSE: KPL), ISIN INE552U01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
KPL last traded at ₹3838.85 (+5.32%), with a 52-week range of ₹1561.00 to ₹3949.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 54.86%, FIIs 2.50%, DIIs 1.07%, mutual funds 0.00%.
EquiSense Score (ECS): 58/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.